Influenza Archives

CDC Merges Flu and COVID Divisions

The Centers for Disease Control and Prevention is merging its Influenza Division with the Coronavirus and Other Respiratory Diseases Division to create the Influenza and Respiratory Viruses Division.

CDC Issues Recommendations for 2026-2027 Influenza Vaccines

The Centers for Disease Control and Prevention has issues its recommendations for use of the seasonal 2026-2027 influenza (flu) vaccines.

FDA Approves First mRNA Influenza Vaccine

The U.S. Food and Drug Administration has approved mFLUSIVA (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older.

High-Dose Flu Vaccine Significantly Lowers Risk of Developing Alzheimer’s (2026)

A UTHealth study found adults 65 and older had a lower risk of developing Alzheimer’s disease after receiving a high-dose flu vaccine.

Flu Vaccine, Even with Infection, Reduces Risk of Heart Attack and Stroke

The Statens Serum Institut in Copenhagen found that flu vaccines may protect against heart attack and stroke, even if the flu is still developed after vaccination.

FDA Approves Moderna’s mRNA Influenza Vaccine

The U.S. Food and Drug Administration’s accines and Related Biological Products Advisory Committee voted to recommend approval of the Moderna’s investigational mRNA influenza vaccine, which will be marketed under the brand name mFlusiva, for the prevention of flu in adults age 50 to 64.

COVID-19 and Influenza Coadministered Vaccines May Loiwer Risk of MACE in Older Adults

According to a recent study, coadministration of the COVID-19 vaccine with the annual influenza vaccine may reduce COVID-19-related major adverse cardiovascular events (MACE) among older adults, especially those with comorbidities. In the study, researchers conducted a target trial emulation using electronic health record data of more than one million veterans (mean age, 70 years; 92 […]